The use of chlorpropamide in brittle and poorly controlled diabetes mellitus. 1959

H L DOBSON, and H GUILAK, and R E CARTER, and H MONTGOMERY, and J A GREENE

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D002747 Chlorpropamide A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277) Clorpropamid,Apo-Chlorpropamide,Diabinese,Glucamide,Insogen,Meldian
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune

Related Publications

H L DOBSON, and H GUILAK, and R E CARTER, and H MONTGOMERY, and J A GREENE
April 2003, Diabetes & metabolism,
H L DOBSON, and H GUILAK, and R E CARTER, and H MONTGOMERY, and J A GREENE
February 1960, Journal of the Indian Medical Association,
H L DOBSON, and H GUILAK, and R E CARTER, and H MONTGOMERY, and J A GREENE
August 1973, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
H L DOBSON, and H GUILAK, and R E CARTER, and H MONTGOMERY, and J A GREENE
January 2017, Internal medicine (Tokyo, Japan),
H L DOBSON, and H GUILAK, and R E CARTER, and H MONTGOMERY, and J A GREENE
February 1960, Hospital (Rio de Janeiro, Brazil),
H L DOBSON, and H GUILAK, and R E CARTER, and H MONTGOMERY, and J A GREENE
November 1958, Journal of the Irish Medical Association,
H L DOBSON, and H GUILAK, and R E CARTER, and H MONTGOMERY, and J A GREENE
January 1974, Medicinski arhiv,
H L DOBSON, and H GUILAK, and R E CARTER, and H MONTGOMERY, and J A GREENE
October 2004, Revista espanola de enfermedades digestivas,
H L DOBSON, and H GUILAK, and R E CARTER, and H MONTGOMERY, and J A GREENE
March 1959, Annals of the New York Academy of Sciences,
H L DOBSON, and H GUILAK, and R E CARTER, and H MONTGOMERY, and J A GREENE
May 1985, The American journal of medicine,
Copied contents to your clipboard!